GlassScriptPhysician profile
Sherry X Zhou
NPI 1740211689
$15,848.22
in general payments reported to CMS, 2019-2025
54 companies · $2,566 in 2025
The $2,566 reported for 2025 was more than what 81% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,535 · 2020: $1,953 · 2021: $1,215 · 2022: $2,087 · 2023: $2,915 · 2024: $2,576 · 2025: $2,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,990 · Gift: $59.40 · Education: $7.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,989.84 |
| Gift | $59.40 |
| Education | $7.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $1,384.14 | 2019-2025 | |
| Mannkind Corporation | $1,341.00 | 2020-2025 | Afrezza |
| Astrazeneca Pharmaceuticals LP | $1,216.86 | 2019-2024 | Farxiga, Lokelma |
| Novo Nordisk INC | $1,199.72 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $1,178.89 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $1,133.37 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $807.11 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $786.42 | 2019-2025 | Tepezza, Evenity, Repatha |
| Cequr Corporation | $767.81 | 2023-2025 | Cequr Simplicity |
| Medtronic, INC. | $625.60 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Corcept Therapeutics | $522.67 | 2022-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $484.12 | 2022-2025 | |
| Insulet Corporation | $411.53 | 2019-2024 | Omnipod |
| Dexcom, INC. | $343.44 | 2019-2025 | Dexcom G6 Transmitter |
| Medtronic Minimed, INC. | $296.79 | 2019-2020 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $274.94 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Horizon Therapeutics Plc | $243.91 | 2022-2023 | Tepezza |
| Xeris Pharmaceuticals, INC. | $227.53 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Abbvie INC. | $204.54 | 2019-2025 | Synthroid |
| Amneal Pharmaceuticals LLC | $195.57 | 2019-2025 | Unithroid |
| Merck Sharp & Dohme LLC | $185.62 | 2019-2020 | |
| Amarin Pharma, INC. | $181.87 | 2019-2022 | |
| Genzyme Corporation | $177.00 | 2019-2020 | |
| Ascendis Pharma Endocrinology INC | $151.30 | 2025 | Yorvipath |
| Ascensia Diabetes Care US INC. | $144.55 | 2023-2025 | |
| Ibsa Pharma INC. | $140.90 | 2019-2025 | Tirosint, Licart, Tirosint |
| Lexicon Pharmaceuticals, INC. | $138.03 | 2024 | Inpefa |
| Antares Pharma, INC. | $98.88 | 2019-2024 | Xyosted |
| Novartis Pharmaceuticals Corporation | $81.35 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $69.04 | 2022 | |
| Pfizer INC. | $68.79 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $68.74 | 2019-2025 | Strensiq |
| Beta Bionics, INC. | $68.46 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Madrigal Pharmaceuticals | $58.43 | 2025 | Rezdiffra |
| Ipsen Biopharmaceuticals, INC | $57.90 | 2019 | |
| Blueprint Medicines Corporation | $51.11 | 2022 | |
| Amryt Pharma Holdings LTD | $48.71 | 2022 | |
| Verity Pharmaceuticals INC. | $46.94 | 2024-2025 | Tlando |
| Janssen Pharmaceuticals, INC | $43.57 | 2019-2020 | |
| Radius Health, INC. | $37.60 | 2023 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.20 | 2019 | |
| Glaxosmithkline, LLC. | $30.45 | 2025 | Shingrix, Arexvy |
| Becton, Dickinson and Company | $26.15 | 2022 | |
| Embecta Corp. | $23.20 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Averitas Pharma INC. | $22.51 | 2023 | Qutenza |
| Lifescan, INC. | $20.82 | 2022 | |
| Nevro Corp. | $20.05 | 2022 | |
| Recordati_rare_diseases_inc. | $19.43 | 2025 | Isturisa |
| Shire North American Group INC | $18.19 | 2019 | |
| Sequel Med Tech, LLC | $17.69 | 2025 | Twiist |
| Esperion Therapeutics, INC. | $16.97 | 2025 | Nexletol |
| Ultragenyx Pharmaceutical INC. | $12.61 | 2022 | |
| Opko Pharmaceuticals, LLC | $11.04 | 2019 | |
| Organon LLC | $8.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.